• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2019, Vol. 21 ›› Issue (12): 718-722.

• 临床医学 • 上一篇    下一篇

保护性肺通气在重症胸部创伤合并急性呼吸窘迫综合征中的临床应用效果

张亮1,王波2,范志强2,武钰2,朱振振2,曹胜胜2,杜西龙2   

  1. 1. 西安仲德骨科医院
    2. 西安仲德骨科医院创伤外科一病区
  • 收稿日期:2020-02-07 修回日期:2019-12-17 出版日期:2019-12-31 发布日期:2019-12-31

Clinical Application Effect of Protective Pulmonary Ventilation in Severe Thoracic Trauma Complicated with Acute Respiratory Distress Syndrome

  • Received:2020-02-07 Revised:2019-12-17 Online:2019-12-31 Published:2019-12-31

摘要: 目的:研究保护性肺通气在重症胸部创伤合并急性呼吸窘迫综合征中的临床疗效。方法:选取我院重症监护科室收治的重症胸部创伤合并急性呼吸窘迫综合征患者80例为本研究对象,随机平均分为对照组和观察组,分别给予常规机械通气处理和保护性肺通气处理,对比两组患者临床疗效和治疗前后不同时间点血气指标、呼吸动力学指标、血流动力学指标水平检测结果。结果:观察组患者治疗后机械通气时间(MVT)、ICU监护时间均短于对照组(P<0.05);观察组患者呼吸机相关性肺炎(VAP)发生率、病死率均低于对照组(P<0.05)。治疗开始后到治疗后1 min的时间内,观察组患者平均动脉压(MAP)、心排血量(CO)平均水平均低于治疗前(P<0.05),5 min后,所有指标均恢复到治疗前水平(P>0.05)。观察组患者治疗后24 h吸气平台压(Pplat)水平低于治疗前(P<0.05),同时与同时间点对照组测量水平比较,治疗后48、72 h低于对照组水平(P<0.05);观察组患者治疗后12 h气道峰压(PIP)水平低于治疗前(P<0.05),同时与同时间点对照组测量水平比较,治疗后12、24、48、72 h低于对照组水平(P<0.05);治疗后肺静态顺应性(Cst)水平与治疗前相比升高,与对照组相比,同时间点检测水平升高(P<0.05)。两组治疗后动脉血氧分压(PaO2)、氧合指数(PaO2/FiO2) 两项指标均高于治疗前,其中观察组患者治疗后同期时间点检测水平高于对照组水平(P<0.05)。pH值、动脉血二氧化碳分压(PaCO2)两项指标比较,两组患者治疗前后变化均无统计学意义(P>0.05)。结论:保护性肺通气可提高重症胸部创伤合并急性呼吸窘迫综合征患者的临床疗效,改善血气、呼吸动力学以及血流动力学等指标水平。

Abstract: Objective: To investigate the clinical application effect of protective pulmonary ventilation in severe thoracic trauma combined with acute respiratory distress syndrome (ARDS), and to analyze the clinical efficacy. Methods: Eighty patients with severe thoracic trauma complicated with ARDS in intensive care unit (ICU) of our hospital were selected as the object of study. They were randomly divided into the control group and the observation group on average, which were treated with conventional mechanical ventilation and protective pulmonary ventilation respectively. The clinical efficacy, blood gas index, respiratory dynamics index and hemodynamic index at different time points before and after treatment were compared between the two groups. Results: The mechanical ventilation time (MVT) and ICU monitoring time after treatment in the observation group were shorter than those in the control group (P<0.05). The incidence of ventilator-associated pneumonia (VAP) and mortality in the observation group were lower than those in the control group (P<0.05). During the period from the beginning of treatment to 1 min after treatment, the average levels of mean arterial pressure (MAP) and cardiac output(CO) in the observation group were lower than those before treatment (P<0.05). 5 min after treatment, all the indexes recovered to the pre-treatment level (P>0.05). The level of Pplat at 24 h after treatment in the observation group was lower than that before treatment (P<0.05), and at 48 h and 72 h after treatment were lower than that in the control group (P<0.05). The level of PIP at 12 h after treatment in the observation group was lower than that before treatment (P<0.05), and was lower at 12 h,24 h, 48 h and 72 h after treatment compared with that in the control group. The level of Cst in the observation group after treatment was higher than that before treatment, and at the same time point was higher than that in the control group (P<0.05). After treatment, PaO2 and PaO2/FiO2 in both groups were higher than those before treatment, and the level of PaO2 and PaO2/FiO2 in the observation group were higher than those in the control group at the same time point after treatment (P<0.05). The pH and PaCO2 before and after treatment had no statistical difference between the two groups (P>0.05). Conclusion: Protective pulmonary ventilation can improve the clinical efficacy, blood gas, respiratory dynamics and hemodynamics of patients with severe thoracic trauma combined with acute respiratory distress syndrome.

中图分类号: